Pharmaceutical

Telomir seeks FDA approval for Telomir-1 to treat breas...

The IND includes results from completed toxicology, pharmacology, and manufactur...

Symeres and Ambagon collaborate for colorectal cancer m...

The partnership aims to explore a new class of small molecules, called molecular...

Enthral.ai partners with Alembic Pharmaceuticals to dep...

Platform to support compliance, training and documentation for over 9,000 lear...

Express Pharma April 2026

India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Ph...

Midst global headwinds, CDSCO cracks down on GLP-1 gold...

As pharma companies deal with price wars, increasing regulatory heat and a vola...

Eli Lilly to acquire Centessa Pharmaceuticals under def...

Acquisition to include orexin receptor portfolio for sleep and neurological co...

Teva receives FDA approval for Prolia biosimilar

The FDA approval of Ponlimsi is based on a comprehensive evidence package, inclu...

uBriGene and Cellinfinity BIO collaborate to accelerate...

The partnership focuses on progressing Cellinfinity BIO’s programmes CIB-301 and...

Rusan unveils APOSAN 3ml multi-dose pen for treatment o...

Rusan Healthcare, the marketing and distribution arm of Rusan Pharma, an integr...

 Granules Life Sciences receives VAI classification fol...

Granules India announced that its wholly owned subsidiary, Granules Life Scienc...

CORONA Remedies announces strategic acquisition of Woka...

CORONA Remedies announced the acquisition of Wokadine from Dr. Reddy’s Laborato...

Otsuka agrees to acquire Transcend Therapeutics for $1....

The deal is anticipated to close in the second quarter of 2026, subject to stand...

Novo Nordisk receives FDA approval for basal insulin Aw...

It is indicated as an adjunct to exercise and diet for improving glycaemic contr...

HRV Pharma, Shodhana partner to accelerate next-gen API...

HRV Pharma, India’s first integrated Virtual API and Pharmtech company announce...

Simulations Plus and three pharma companies collaborate...

The partnerships aim to apply AI within scientifically validated modelling workf...

Novartis to acquire Excellergy for $2bn upfront

The acquisition will provide access to Exl-111, a half-life extended, high-affin...